The markets traded mixed during the midday with the Dow losing 52 points to 16,859 while Nasdaq rose 9 points to 4451 over interest rate concerns.
On the upside
Chicago Mercantile Exchange Group will acquire GFI Group (NYSE: GFIG) in a deal valued at approximately $580 million.
Galectin Therapeutics (Nasdaq: GALT) issued a statement affirming its positive trial results for a phase 1 clinical trial of its GR-MD-02 in treating patients with NASH with advanced fibrosis.
Zeltiq Aesthetics (Nasdaq: ZLTQ) swung to a better than expected profit for the second quarter as revenue surged and lifted its full year revenue guidance.
On the downside
The Goodyear Tire & Rubber Co. (Nasdaq: GT) reported higher second quarter earnings but revenue fell to miss analyst expectations.
Buffalo Wild Wings (Nasdaq: BWLD) reported higher second quarter earnings and revenue but the restaurant chain forecast full year earnings below expectations.
Second quarter earnings rose for Dorman Products (Nasdaq: DORM) but the results fell short of expectations.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE while advancers edged out decliners by more than 5 to 4 on Nasdaq. The broader S&P 500 slipped 2 points to 1967. Bitcoin lost $8 to $572.